The relative abilities of some compounds to inhibit the transformation of amorphous calcium phosphate into hydroxyapatite were determined. Organic diphosphates, fructose 1,6-bisphosphate, pyrophosphate, imidodiphosphate and 3-phosphoglycerate all inhibited to various degrees. Strong inhibition was observed with phosphonoformate, and phosphocitrate proved to be the most powerful of the inhibitors examined. On the basis of these new findings an improved concept of the structure-activity relationship of inhibitors is proposed and mechanisms for inhibitor action are discussed.
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The process of calcium phosphate deposition is fundamental to the formation of renal stones, mitochondrial granules and the hydroxyapatite of bone (Posner, 1973; Lehninger, 1977; Bygrave, 1978; Fleisch, 1978) . Amorphous calcium phosphate is recognized as the precursor of hydroxyapatite both in vitro (Eanes & Meyer, 1977; Meyer & Eanes, 1978a,b) and in vivo (Dougherty, 1978; Posner & Betts, 1975) . The ability of certain compounds to inhibit the conversion of amorphous calcium phosphate into hydroxyapatite has been extensively examined (Termine et al., 1970; Sutor et al., 1978) . Pyrophosphate, for example, is a potent inhibitor of this conversion and appears to be important to bone mineralization (Fleisch & Russell, 1972) . Other small ions such as Mg2+ and citrate are also inhibitors and, together with pyrophosphate, are considered to account for 77 % of the 'inhibitory power' of urine (Bisaz et al., 1978) . ATP and Mg2+ have been shown to have a synergistic effect on the inhibition of the transition of amorphous calcium phosphate into hydroxyapatite and are believed to stabilize mitochondrial deposits of amorphous calcium phosphate (Blumenthal et al., 1977) .
Despite the range of compounds known to inhibit the transition and the mechanisms proposed to explain their activity, little definitive information has been published to enable a structure-activity relationship of inhibition to be deduced. It has been suggested that there is a link between an H203P-X-P03H2 structure (X = C, N or 0) and inhibitor activity (Robertson & Fleisch, 1970) , but the findings that fructose 1,6-bisphosphate and glycerol 2,3-bisphosphate can inhibit led Termine & Cohn (1976) (Howard, 1976; Lehninger et al., 1978) , whereas the inhibitory power of phosphonoformate is unknown. In the present paper, we report on the ability of phosphocitrate and phosphonoformate to inhibit the transition of amorphous calcium phosphate into hydroxyapatite compared with that of other inhibitors. On the basis of the new data, a modified structure-activity relationship is proposed from which other compounds might be recognized as calcification inhibitors.
Materials and Methods
The transformation of amorphous calcium phosphate into hydroxyapatite was followed titrimetrically essentially as described by Meyer & Eanes (1978a) . Portions (5.Oml) of 0.50M-CaCI2 and 0.50M-NaH2PO4 were added to 600ml of stirred high-purity decarbonated water and equilibrated in a water bath. Sufficient 2M-NaOH was added over 90s to adjust the pH to 7.40. The mixture was maintained at this pH by the addition of 0.05 M-NaOH by using a pH-stat (Radiometer, Copenhagen, Denmark). Care was taken to exclude CO2 from the system. The induction time (I,) was measured as outlined by Meyer & Eanes (1978a) . The difference in induction time with or without an inhibitor is designated AI, and reflects the ability of a particular concentration of a compound to inhibit the transformation of amorphous calcium phosphate into hydroxyapatite. Inhibitory ability was measured at either 20 or 30°C. At 20°C any changes in the I, were highlighted, whereas at 30°C I, values were considerably shortened, but the same trends in inhibitor strength were observed. Hence 30°C was used as a routine since it facilitated a more rapid determination of inhibitory power.
Adenosine phosphates, fructose phosphates, 3-phosphoglycerate and aminoethylphosphonic acid were products from Calbiochem, Sydney, N.S.W., Australia. Imidodiphosphate was prepared as outlined by Yount (1974) , and phosphocitrate was synthesized from 2-cyanoethyl phosphate and triethyl citrate (G. Williams, unpublished work). Phosphonoformate was a generous gift from Astra Lakemedal A.B., Sudertalje, Sweden. All chemicals were reagent grade.
Results and Discussion
As shown in Fig. 1 (Fleisch, 1978) . The finding of this remarkable inhibitory ability of phosphocitrate adds support to the suggestion that it may be the potent calcification inhibitor isolated from natural sources by others (Howard, 1976; Lehninger et al., 1978) . Fig. 2 shows the results obtained with a wide range of compounds selected for structural features thought to influence inhibitor power. Of interest was the finding that phosphonoformate inhibited hydroxyapatite formation to a degree that was similar to that obtained with pyrophosphate, a compound accepted to be a strong inhibitor of calcification. Thus the fact that phosphonoformate (carboxylic monophosphate) and phosphocitrate (carboxylic phosphate ester) can both inhibit hydroxyapatite formation necessitates re-examination of the concept proposed by Termine & Cohn (1976) that at least two phosphate ester groups are required for activity. Citric acid was found to be a poor inhibitor over the concentration range tested (0.01-0.2mM), whereas (not shown in Fig. 2> On consideration of the proximity of the two prime groups, it is evident that the closer they are together the more active is the molecule as an inhibitor. For example, pyrophosphate is more active than fructose 1,6-bisphosphate, and phosphonoformate inhibits to a greater degree than 3-phosphoglycerate. When the minimum requirement of a phosphate and an acidic group is fulfilled, it appears that the addition of further chelating groups to an inhibitor molecule confers increased inhibitory ability. Thus ATP is a more powerful inhibitor than ADP, and phosphocitrate inhibits to a greater degree than either phosphonoformate or 3-phosphoglycerate. In a study of the ability of multidentate organic phosphonates to inhibit hydroxyapatite formation, the number of chelating groups and their proximity to one another have been found to influence inhibitory power (Meyer & Nancollas, 1973) . These findings conform to our proposals.
Despite the minimum group requirements, the stereochemical arrangement of these groups also must be important. For example, Meyer & Nancollas (1973) showed that 1-hydroxyethane-1,2-diphosphonate was a stronger inhibitor of hydroxyapatite formation than was nitrilotri(methylenephosphonic acid), even though the latter possessed three phosphate groups. Thus it was suggested that the tetrahedral carbon atom in 1-hydroxyethane-1,2-diphosphonate was superior to the trigonal nitrogen atom as a centre for radiating chelating groups. In this regard it is noteworthy that phosphocitrate possesses a tetrahedral carbon atom from which four chelating 'arms' radiate. The stereochemical factor may give the molecule extra affinity for hydroxyapatite defect sites.
Although our data do not allow positive identification of the modes of action of the inhibitors, it is useful to consider other factors that might affect inhibitor action and activity. All the inhibitors have the potential to chelate Ca2+, but inhibition is not due to Ca2+ chelation as such because EGTA does not significantly alter I. Neither is activity due to attachment of a sterically bulky group to a phosphate moiety, since p-nitrophenyl phosphate (with a P-O-C linkage) and 1-and 2-aminoethylphosphonic acid (with a P-C linkage) failed to inhibit the transformation. Inhibition might have been expected if it were difficult to incorporate sterically bulky molecules into the hydroxyapatite lattice thus making hydroxyapatite energetically less favoured.
Obviously other inhibitory mechanisms are possible. From studies with ATP as an inhibitor Blumenthal et al. (1977) have suggested that the transition of amorphous calcium phosphate into hydroxyapatite occurs only after ATP is hydrolysed, thus removing this inhibitor of hydroxyapatite nucleation.
Another mechanism might be the adsorption of inhibitor molecules on particles of amorphous calcium phosphate, thus altering the lability and solubility of this material and affecting its stability relative to hydroxyapatite. Evidence for this concept comes from i.r. studies, which have shown that inhibitors have a strong affinity for amorphous calcium phosphate (Termine & Cohn, 1976) . Inhibition of crystal growth is yet another possible mode of action, since the apparent solubility may then be greater than the thermodynamic solubility of the crystal material (Finlayson, 1978) . 1-Hydroxyethane-1,2-diphosphonate is a crystal-growth inhibitor demonstrated to have this effect on brushite. Crystal growth is considered to proceed from defect sites, so molecules with affinity for crystal defects will, in our experimental system, destabilize hydroxyapatite. Of the compounds tested here, pyrophosphate and imidodiphosphate are both known inhibitors of hydroxyapatite crystal growth and delayed the transition of amorphous calcium phosphate into hydroxyapatite, as did phosphocitrate, which may have a stereochemistry especially suited to binding at defect sites.
Despite the range of inhibitory mechanisms possible, it is evident from our study that there is a certain minimum structural requirement to be fulfilled before a molecule can inhibit. We suggest that it should possess at least a phosphate group and an acidic group, the latter being either a phosphate group or a carboxylic acid group. These groups may confer to the molecule a special affinity for a calcium phosphate surface. Secondary stereochemical and structural factors will then determine what sites on amorphous calcium phosphate or hydroxyapatite are preferred. Once a molecule can bind sufficiently to the calcium phosphate surface then there exist many mechanisms, as discussed above, by which the transition of amorphous calcium phosphate into hydroxyapatite can be inhibited.
